Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
Sales | 247 | 208 | 162 | 189 | 467 |
Cost of Goods | N/A | N/A | N/A | 7 | 53 |
Gross Profit | 247 | 208 | 162 | 182 | 414 |
Operating Expenses | 950 | 1,536 | 846 | 885 | 2,388 |
Operating Income | -703 | -1,328 | -684 | -696 | -1,921 |
Interest Expense | 137 | 122 | 97 | 96 | 43 |
Other Income | -11,667 | 591 | -294 | 635 | 3,564 |
Pre-tax Income | -12,507 | -859 | -1,075 | -157 | 1,600 |
Net Income Continuous | -12,507 | -859 | -1,075 | -157 | 1,600 |
Net Income | $-12,507 | $-859 | $-1,075 | $-157 | $1,600 |
EPS Basic Total Ops | -631.50 | -76.50 | -91.50 | -44.25 | 37.50 |
EPS Basic Continuous Ops | -596.91 | -41.50 | -57.31 | -7.72 | 79.64 |
EPS Diluted Total Ops | -631.50 | -76.50 | -79.75 | -44.25 | 37.50 |
EPS Diluted Continuous Ops | -596.91 | -41.50 | -55.28 | -7.72 | 78.53 |
EBITDA(a) | $-703 | $-1,328 | $-683 | $-695 | $-1,921 |